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Abstract
Background: overweight or obesity at ages <65 years associates with increased dementia incidence, but at ≥65 years esti-
mates are paradoxical. Weight loss before dementia diagnosis, plus smoking and diseases causing weight loss may confound
associations.
Objective: to estimate weight loss before dementia diagnosis, plus short and longer-term body mass index associations
with incident dementia in 65–74 year olds within primary care populations in England.
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Methods: we studied dementia diagnosis free subjects: 257,523 non-smokers without baseline cancer, heart failure or multi-
morbidity (group A) plus 161,927 with these confounders (group B), followed ≤14.9 years. Competing hazard models
accounted for mortality.
Results: in group A, 9,774 were diagnosed with dementia and in those with repeat weight measures, 54% lost ≥2.5 kg dur-
ing 10 years pre-diagnosis. During <10 years obesity (≥30.0 kg/m2) or overweight (25.0 to <30.0) were inversely associated
with incident dementia (versus 22.5 to <25.0). However, from 10 to 14.9 years, obesity was associated with increased
dementia incidence (hazard ratio [HR] 1.17; 95% CI: 1.03–1.32). Overweight protective associations disappeared in longer-
term analyses (HR, 1.01; 95% CI: 0.90–1.13). In group B, (n = 6,070 with incident dementia), obesity was associated with
lower dementia risks in the short and longer-term.
Conclusions: in 65–74 year olds (free of smoking, cancer, heart failure or multi-morbidity at baseline) obesity associates
with higher longer-term incidence of dementia. Paradoxical associations were present short-term and in those with likely
confounders. Reports of protective effects of obesity or overweight on dementia risk in older groups may reflect biases,
especially weight loss before dementia diagnosis.
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Key points
• In older frailty-free groups, are overweight or obesity protective for later development of dementia?
• Using weight measures from primary care records, weight loss was common during the 10 years before dementia
diagnosis.
• Longer-term (10–14.9 years from baseline), obesity increased the risk of incident dementia.
• Claimed benefit of being obese to avoid dementia at ages 65–74 years is likely an artefact of pre-diagnosis weight loss.
• Avoiding obesity may contribute to dementia prevention, even in older groups.
Introduction
Dementia is a major health challenge and in the absence of a
treatment, there is great interest in modifiable risk factors.
For middle aged adults, most studies report increased
dementia risk for body mass index (BMI) obese range
(≥30.0 kg/m2) subjects versus the normal range (18.5 to
<25.0) [1–3]. However, an electronic health records analysis
(ages ≥40 years) cast doubt on this association, reporting
reduced dementia risks in overweight subjects versus BMI
20.0 to <25.0 [4]. However, a recent meta-analysis including
this above study showed midlife (aged 35–65 years) obesity
associates with increased dementia risk [5]. For older aged
adults (aged ≥65 years) and especially 65–74 year olds, obes-
ity and dementia associations are particularly unclear [6–10].
Weight loss precedes a clinical diagnosis of dementia by at
least a decade [11–13] and could obscure BMI associations.
Greater weight loss in the 6 years preceding dementia diagno-
sis (versus those without dementia) was reported in Japanese
American men [11]. Knopman et al. [12] found increasing
weight differences in women (but not men) present for 20
years before dementia diagnosis, with e.g. 8.0 pounds median
weight loss 10 years pre-diagnosis versus 2.0 pounds (median)
for those without dementia, with a similar finding from
LeBlanc et al. [13]. Thus pre-diagnosis weight loss would
lower BMI, and could potentially produce ‘reverse causation
biases’ in shorter-term (<10 years) estimates. Examining asso-
ciations with BMI measures >10 years before outcome ascer-
tainment is less likely to be confounded by pre-diagnosis
weight loss. Furthermore, smokers have lower weight but
high mortality [14], tending to die of competing causes before
dementia diagnosis. Additionally, smokers have been shown
to be at a higher dementia risk [15]. We also showed that
weight loss is most strongly associated with cancer, heart fail-
ure and multi-morbidity in older primary care patients [16].
Overall, there are consistent BMI dementia associations
for ages <65 years, but it remains unclear whether raised
BMI at ages 65–74 is a risk or protective factor for demen-
tia. Here we used the Clinical Practice Research Datalink
(CPRD) linked primary and secondary care health records
for complete older populations in England registered with
primary care providers. We considered two groups without
dementia at baseline: group A excluding suggested con-
founders (i.e. smoking, cancer, heart failure or multi-
morbidity at baseline) and group B with these confounders.
First, we estimated the prevalence of BMI categories in
those in group A who developed incident dementia in each
year before diagnosis. We then estimated shorter (0 to <10
years from baseline BMI measure) and longer-term (10–14.9
years) associations between BMI and dementia diagnosis in
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groups A and B. Using this dichotomy allows us to take into
account the 10 years pre-diagnosis weight loss, and to examine
the prognostic value of BMI in the longer-term.
Methods
Data source
The CPRD includes health records from 674 UK primary
care practices [17]. Our analysis included records linked to
Hospital Episode Statistics data for admissions (linkage
available for English practices only) and the Office for
National Statistics (ONS) death certificates (see methods
Appendix 1 for further details, in the supplementary data,
available in Age and Ageing online).
Participants
Previously we showed that BMI records were available from 1
January 2000 for 62% of patients (n = 955,031) in CPRD prac-
tices aged ≥60 years [16]. We excluded extreme BMI values
(<14.0 and >56.5) (n = 6,431) and selected individuals aged
65–74 years with at least one recorded BMI and registered with
a practice from 1 January 2000 to 17 November 2014. We
stratified our analysis into non-smokers without cancer, heart
failure, or multi-morbidity at baseline (termed group A, to min-
imise confounding) and those with these confounders (termed
group B), as these conditions were most closely associated with
weight loss in our previous analysis [16]. Patients with 6 or
more Rockwood frailty index conditions (of 36) were defined
as having multi-morbidity [18], using ResearchOne Electronic
Frailty Index coding rules covering diagnoses, functional impair-
ments, health attitudes and symptoms. We excluded patients
with a dementia diagnosis at baseline and patients who were
missing information on smoking history, alcohol status or
relative socioeconomic status (Figure Appendix 2, in the sup-
plementary data, available in Age and Ageing online).
BMI records
The earliest age within the 65–74 years range at which BMI
was recorded was used as the study ‘index’ (baseline) BMI
for analysis. BMI (kg/m2) was categorised following the
Global BMI Mortality Collaboration groupings [19] as BMI
<18.5, 18.5 to <20.0, 20.0 to <22.5, 22.5 to <25.0, 25.0
to <30.0 and ≥30.0. The higher risk for dementia reported in
the lower end of the conventional normal range (BMI 18.5 to
<25.0 compared to higher BMIs), may distort estimates: we
therefore adopted the Global BMI Mortality Collaboration
BMI groupings [19].
Weight change
We analysed individual subject weight change (kg) for those
who had dementia diagnosed during follow-up. We sub-
tracted the median recorded weight in the 3 years immedi-
ately before dementia diagnosis from the median weight
recorded 8–10 years before diagnosis, where available.
Covariates
We adjusted the models for: age, gender, smoking history,
alcohol intake, relative socioeconomic status and calendar
year (see methods Appendix 1 for further details, in the
supplementary data, available in Age and Ageing online).
Outcomes
Outcomes included incident clinically diagnosed dementia
(in primary care or hospital records), and mortality (from
ONS death certificate data) to 17 November 2014.
Statistical analysis
For patients diagnosed with dementia during follow-up, we
first calculated proportions of patients in each BMI category
in the years before dementia diagnosis. We then calculated
the weight change, where available, for those with incident
dementia in group A. We used Fine and Gray competing
risks models (with all-cause mortality as the competing risk)
to estimate BMI category associations with incident demen-
tia [20]. Adjustments were for age, gender, alcohol use,
smoking history, calendar year and socioeconomic status.
Sensitivity analyses (i) adjusted the model for prevalent stroke
or prevalent depression at baseline and (ii) excluded those
with diagnosed angina, myocardial infarction or diabetes at
baseline. Stata statistical software (version 14.1) was used.
Results
Group A: associations in subjects without suggested
confounders
Analyses included 257,523 non-smokers, without diagnoses of
cancer, dementia, heart failure or multi-morbidity, aged 65–74
years at baseline. During the ≤14.9 years of follow-up there
were 9,774 incident cases of dementia and 29,466 deaths. The
mean baseline BMI was 27.7 kg/m2 (sd 4.9 kg/m2), and
53.4% of the sample were females (Table 1).
In the 9,774 subjects with incident dementia, we calcu-
lated the proportions of patients in each BMI category in
the years before diagnosis of dementia. This showed lower
obesity prevalence in those diagnosed sooner after baseline
(Figure 1), with for example 15.5% of those diagnosed with
dementia in the first year of follow-up being obese, com-
pared to 23.4% for those diagnosed in the 9th year of
follow-up. Underweight (BMI < 18.5) and leaner normal
weights (18.5 to <20.0) showed converse changes
(Figure 1). We then analysed individual subject weight
change (see Methods). Records allowed weight change cal-
culations for 4,760 (48.7%) patients with dementia and of
these 67.7% lost weight with 54.0% loosing ≥2.5 kg during
the decade before diagnosis.
Competing risk models (accounting for mortality) were
adjusted for age, gender, smoking history, alcohol intake,
socioeconomic status and calendar year. From analysis
baseline to <10 years of follow-up (Figure 2), both obesity
and overweight had protective associations for incident
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dementia (obesity sub-Hazard Ratio [SHR], 0.69; 95% CI:
0.65–0.74, relative to BMI 22.5 to <25.0). However, for the
longer-term follow-up (between 10 and 14.9 years from
baseline), baseline obesity was associated with increased
incidence of dementia (HR, 1.17; 95% CI: 1.03–1.32 versus
BMI 22.5 to <25.0). In the longer-term follow-up, those
defined as overweight had similar hazards for dementia to
the control group. In models pooling shorter and longer
follow-ups (Table Appendix 3, in the supplementary data,
available in Age and Ageing online), the shorter-term protect-
ive associations predominated, although with smaller overall
sub-Hazard Ratios than for the 0 to <10 year period only.
Interestingly, low BMIs were consistently associated with
raised risks of dementia in both the shorter and longer-term.
Sensitivity analyses for group A
In a further analysis, we additionally adjusted for prevalent
depression or prevalent stroke diagnosed at baseline, results
were little changed (Table Appendix 4, in the supplementary
data, available in Age and Ageing online). As obesity is a
major risk factor for coronary artery disease (MI and
angina) and diabetes we estimated the associations excluding
those diagnosed with these conditions, this reduced the
sample size to 49,341 and attenuated the 10–14.9 year
results only slightly (obesity HR, 1.16; 95% CI: 1.01–1.33)
Figure 2 Competing hazards for incident dementia by BMI
categories for Groups A and B, for 0 to <10 years and 10–14.9
years from baseline. Group A were non-smokers without recent
cancer (within the previous 5 years except non-melanoma skin
cancer), dementia, heart failure or multi-morbidity: Group B
were patients who were either currently smoking, had a diagno-
sis of recent cancer (within the previous 5 years except non-
melanoma skin cancer), heart failure or multi-morbidity.
Figure 1 Percentage of group A (non-smokers without recent
cancer, heart failure or multi-morbidity) with incident demen-
tia by BMI categories.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 1. Characteristics of the study sample aged 65–74
years at baseline from the CPRD
Group Aa Group Bb
n 257,523 161,927
Follow-up years, mean (sd) 6.2 (4.1) 5.3 (3.8)
Age years, mean (sd) 68.3 (2.9) 67.8(2.8)
Gender
Females, n (%) 137,583 (53.4) 75,584 (46.7)
BMI (kg/m2), mean (sd) 27.7 (4.9) 27.7 (5.5)
BMI (kg/m2), n (%)
BMI <18.5 2,367 (0.9) 3,626 (2.2)
BMI 18.5 to <20.0 4,553 (1.8) 4,431 (2.7)
BMI 20.0 to <22.5 22,225 (8.6) 15,646 (9.7)
BMI 22.5 to <25.0 48,577 (18.9) 27,906 (17.2)
BMI 25.0 to <30.0 109,195 (42.4) 62,633 (38.7)
BMI ≥30.0 70,606 (27.4) 47,685 (29.5)
Alcohol status, n (%)
Non-drinker 38,696 (15.0) 21,775 (13.5)
Current drinker 179,839 (69.8) 101,136 (62.5)
Ex drinker 34,264 (13.3) 36,299 (22.4)
Heavy drinker 4,724 (1.8) 2,717 (1.7)
Smoking status, n (%)
Never 161,063 (62.5) 20,404 (12.6)
Ex-smoker 96,460 (37.5) 125,265 (77.4)
Currently smoking – 16,258 (10.0)
Index of multiple deprivation quintiles
(1 least deprived; 5th most deprived), n (%)
1 66,513 (25.8) 29,009 (17.9)
2 68,028 (26.4) 36,590 (22.6)
3 54,263 (21.1) 34,208 (21.1)
4 44,326 (17.2) 35,192 (21.7)
5 24,393 (9.5) 26,928 (16.6)
aSample were non-smokers without recent cancer (within the previous 5 years
except non-melanoma skin cancer), dementia, heart failure or multi-morbidity.
bSample were patients who were either currently smoking, had a diagnosis of
recent cancer (within the previous 5 years except non-melanoma skin cancer),
heart failure or multi-morbidity.
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(Table Appendix 5, in the supplementary data, available in
Age and Ageing online).
Group B: associations in subjects with suggested
confounders at baseline
Analyses included 161,927 patients with either a diagnosis of
cancer, heart failure, multi-morbidity or patients who were
currently smoking. During the ≤14.9 years of follow-up there
were 6,070 incident cases of dementia and 36,425 deaths.
The mean baseline BMI was 27.7 kg/m2 (sd 5.5 kg/m2), and
46.7% of the sample were females (Table 1).
From analysis baseline to <10 years of follow-up
(Figure 2), obesity and overweight had protective associa-
tions for incident dementia (obesity SHR, 0.79; 95% CI:
0.72–0.86, relative to BMI 22.5 to <25.0). The risk of
dementia remained reduced for the longer-term follow-up
(between 10 and 14.9 years from baseline) (obesity SHR,
0.82; 95% CI: 0.69–0.97 versus BMI 22.5 to <25.0)
(Figure 2). In the longer-term follow-up, those defined as
overweight had similar hazards for dementia to the control
group. There were increased dementia risks for those with
low BMIs during the shorter term. In the longer-term, the
hazards were similar to the control group.
Discussion
We studied shorter and longer-term associations between
BMI and incident dementia in two groups within the older
population: group A, excluding suggested confounders (i.e.
smoking, cancer, heart failure or multi-morbidity at baseline)
and group B with these confounders. Group A were selected
to be typical of those targeted with general health advice
about the risks of being overweight or obese, while group B
would need specific advice tailored to their context. In group
A we confirmed substantial weight loss for 10 years before
dementia diagnosis. During the full follow-up obesity
appeared paradoxically protective for dementia incidence,
but for longer-term outcomes (10–14.9 years after BMI
measurement) the risk estimate reversed. Similarly, over-
weight protective associations disappeared in the longer-
term. In group B with confounding conditions, raised BMI
appeared protective for dementia in the short and longer-
term, likely reflecting reverse causation with baseline BMI
determined in part by smoking, cancers, heart failure and
multi-morbidity, i.e. reflecting effect rather than cause.
Our finding of lower portions of subjects with obesity
in those diagnosed sooner after baseline is consistent with
previous reports of weight loss during the pre-clinical devel-
opment of dementia [12]. Amongst those diagnosed with
dementia (group A) 54% of those with repeat measures lost
≥2.5 kg during the decade before diagnosis. Stewart et al.
[11] found that 30% of the Japanese American men who
developed dementia lost ≥5 kg between two examination
periods (1994–96 to 1997–99) compared to 12% of the
men who did not develop dementia [11].
Our results for the whole follow-up period are partly in
line with the previous analysis by Fitzpatrick et al. [8] who
reported reduced dementia risk for those with obesity aged
65–97 years. Atti et al. studied a cohort aged ≥75 years,
using an older cohort than used here, with overweight and
obesity combined. For the whole follow-up period (0–9
years), overweight and obesity combined were associated
with a reduced dementia risk (HR, 0.75; 95% CI: 0.59–0.96
versus BMI 20.0–24.9). After excluding the first 6 years the
dementia risk estimates were only a little attenuated (HR,
0.66; 95% CI: 0.40–1.07) [21].
Our results, are in-accordance with a recent analysis of indi-
vidual level data from 39 cohorts, which showed a protective
effect of BMI when measured closer to dementia diagnosis
(<10 years), although the mean age at BMI measurement in
these studies was under 65 years. However, in the longer-term
higher BMI was associated with an increased dementia risk.
The majority of the included cohorts had a baseline period pre
2000 (from 1965 to 1999) when the prevalence of overweight
and obesity were much lower than they are now [22].
We additionally, estimated the short and longer-term
BMI associations for patients who either had a diagnosis of
cancer, heart failure, or multi-morbidity or were currently
smoking (group B). These diseases were found to be asso-
ciated with weight loss in our previous analysis using the
CPRD [16], and as noted, smoking is associated with lower
weight and high mortality [14]. As baselines BMIs in group
B are likely influenced as a result of these factors, the para-
doxical associations are difficult to interpret, and likely
merely reflect reverse causation. Future work should exam-
ine associations with BMI recorded several years before the
development of cancers, heart failure or multi-morbidity, to
obtain valid estimates preferably in big enough groups to
examine the effects of these factors separately.
Limitations include that the population studied was pre-
dominately of British ‘white’ ethnicity and more work is
needed in other groups. Risks for dementia subtypes (mainly
Alzheimer’s and vascular dementia) could not be examined,
although dementia in older groups tends to have mixed path-
ologies [23, 24]. Unfortunately no data were available on
some risk factors including head injuries or hearing loss,
although it is difficult to see how these could confound obes-
ity dementia associations. CPRD data are recorded during
routing practice, with BMI often recorded opportunistically,
e.g. at first registration with the practice, but also more fre-
quently for patients with relevant conditions, possibly
introducing selection biases. However, during the study
period, GPs were financially incentivised to maintain a
register of those with obesity [25]. Further, BMI record-
ing were included in the NHS Health Check programme
(implemented in our study period), which assess 40–74
year olds without diabetes or cardiovascular disease [26].
Both of these funded initiatives resulted in improved
recording of BMI in primary care. Also recording biases
from sicker patients seeing GPs more often are likely to
affect the shorter-term associations, and be minimised by
our analysis of outcomes 10 years after BMI recording.
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This study also has considerable strengths, including the
large complete older primary care populations plus no inform-
ative loss to follow-up (i.e. loss of people who develop demen-
tia) which is often seen in research cohorts [27]. The results
extend previous findings for 65–74 year olds, and should
encourage better management of excessive weight gain, with-
out the confusion of claimed protective effects for dementia.
Future work could focus on testing longer-term associa-
tions with more detailed individual measures of weight
dynamics. Additionally, potential interactions between weight
loss and BMI categories should be examined using repeat
BMI measures on a whole group of individuals rather than
subsets of patients. Future studies could also examine longer-
term associations between BMI and cognitive impairments.
Conclusions
In 65–74 year olds (free of smoking, cancer, heart failure,
multi-morbidity or dementia at baseline), being obese is
associated with increased incidence of dementia in the
longer-term. Paradoxical long-term associations were pre-
sent in the group with likely confounders. Previous reports
of protective effects of obesity or overweight on dementia
risk in older groups likely reflect biases, especially weight
loss during the pre-clinical development before dementia.
Supplementary data mentioned in the text are available to
subscribers in Age and Ageing online.
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Abstract
Objective: to determine whether a 4-week postoperative rehabilitation program delivered in Nursing Care Facilities (NCFs)
would improve quality of life and mobility compared with receiving usual care.
Design: parallel randomised controlled trial with integrated health economic study.
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